Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ · Healthcare
Regeneron Pharmaceuticals, Inc. Total Assets 2008–2025
Regeneron Pharmaceuticals, Inc. annual total assets history from 2009 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Regeneron Pharmaceuticals, Inc. total assets as of December 31, 2025: 40.56B, a 7.41% increase year-over-year.
- Regeneron Pharmaceuticals, Inc. total assets for 2025 were 40.56B, a 7.41% increase from 2024.
- Regeneron Pharmaceuticals, Inc. total assets for 2024 were 37.76B, a 14.15% increase from 2023.
- Regeneron Pharmaceuticals, Inc. total assets for 2023 were 33.08B, a 13.23% increase from 2022.
- Regeneron Pharmaceuticals, Inc. total assets for 2022 were 29.21B.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Regeneron Pharmaceuticals, Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2025 | $40,559 |
| 2024 | $37,759 |
| 2023 | $33,080 |
| 2022 | $29,215 |
| 2021 | $25,435 |
| 2020 | $17,163 |
| 2019 | $14,805 |
| 2018 | $11,735 |
| 2017 | $8,764 |
| 2016 | $6,973 |
| 2015 | $5,609 |
| 2014 | $3,838 |
| 2013 | $2,951 |
| 2012 | $2,080 |
| 2011 | $1,324 |
Regeneron Pharmaceuticals Inc. Total Assets — FAQ
Regeneron Pharmaceuticals Inc. (REGN) total assets over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REGN's total assets history?
The chart and table above show Regeneron Pharmaceuticals Inc.'s total assets by year and by quarter, including the growth rate.